返回 Agenda
Session 8A: Podium Pearls
Session Chair(s)
Julia Petses, PharmD
Global Head, Medical Information Excellence and SEC Established and Rare Franchi, Novartis, United States
Medical communications professionals will be presenting their successes, challenges, and “pearls of wisdom” on various topics through podium presentations.
Learning Objective : At the conclusion of this session, participants should be able to:
•Discuss and share best practices, experiences, and innovative processes for medical communications topics related to social media, new technologies, information exchange platforms, and expanding medical information roles
Speaker(s)
Rania Gaspo, PhD
Director, Global Therapy Area Team Lead, External Medical Communications, Pfizer Inc, Canada
US MEDICAL INFORMATION WEBSITES BENCHMARKING: HOW IS THE INDUSTRY FAIRING IN USABILITY?
Taleen Kalebjian, PharmD
Senior Manager, Medical Information , Gilead Sciences, Inc., United States
SYSTEMATIC PROACTIVE REVIEW OF ONLINE DRUG COMPENDIA MONOGRAPHS
Sarika Sood, MD
Sr. Director Global Medical Information, Abbvie, United States
COMPARISON OF MEDICAL INFORMATION SERVICES PRE- AND POST- SPLIT OF A PHARMA COMPANY: COMBINING TWO CUSTOMER FEEDBACK METHODS
Thomas Malieckal, PharmD
Sr Director, Global Medical Information, Celgene, United States
EFFECTIVE GLOBALIZATION IN A MATRIX ORGANIZATIONAL STRUCTURE
Brandi Fannon Gregg, PharmD
HCP Associate, UCBCares, UCB, Inc. , United States
ADDING CLARITY BEYOND VERBAL RESPONSE ONLY: PROVIDING WRITTEN MEDICAL INFORMATION RESPONSES TO PATIENTS
Alicia Cadogan, PharmD, RPh
Category Lead, Oncology Medical Information and Review, Pfizer, Inc, United States
MEDICAL INFORMATION (MI) SOCIAL MEDIA ACTIVITIES: IMPACT OF POST TYPE AND REFERRALS TO MI